Severe acute respiratory syndrome (SARS) -: paradigm of an emerging viral infection

被引:85
作者
Berger, A
Drosten, C
Doerr, HW
Stürmer, M
Preiser, W
机构
[1] Goethe Univ Frankfurt, Inst Med Virol, D-60596 Frankfurt, Germany
[2] Bernhard Nocht Inst Trop Med, Hamburg, Germany
关键词
severe acute respiratory syndrome (SARS); coronavirus; SARS-associated coronavirus (SARS-CoV); laboratory diagnosis; transmission; emerging infection; epidemiology; antiviral treatment; World Health Organization (WHO);
D O I
10.1016/j.jcv.2003.09.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An acute and often severe respiratory illness emerged in southern China in late 2002 and rapidly spread to different areas of the Far East as well as several countries around the globe. When the outbreak of this apparently novel infectious disease termed severe acute respiratory syndrome (SARS) came to an end in July 2003, it had caused over 8000 probable cases worldwide and more than 700 deaths. Starting in March 2003, the World Health Organization (WHO) organised an unprecedented international effort by leading laboratories working together to find the causative agent. Little more than one week later, three research groups from this WHO-coordinated network simultaneously found evidence of a hitherto unknown coronavirus in SARS patients, using different approaches. After Koch's postulates had been fulfilled, WHO officially declared on 16 April 2003 that this virus never before seen in humans is the cause of SARS. Ever since, progress around SARS-associated coronavirus (SARS-CoV) has been swift. Within weeks of the first isolate being obtained, its complete genome was sequenced. Diagnostic tests based on the detection of SARS-CoV RNA were developed and made available freely and widely; nevertheless the SARS case definition still remains based on clinical and epidemiological criteria. The agent's environmental stability, methods suitable for inactivation and disinfection, and potential antiviral compounds have been studied, and development of vaccines and immunotherapeutics is ongoing. Despite its grave consequences in humanitarian, political and economic terms, SARS may serve as an example of how much can be achieved through a well-coordinated international approach, combining the latest technological advances of molecular virology with more "traditional" techniques carried out to an excellent standard. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 67 条
[51]   Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection [J].
Ruan, YJ ;
Wei, CL ;
Ee, LA ;
Vega, VB ;
Thoreau, H ;
Yun, STS ;
Chia, JM ;
Ng, P ;
Chiu, KP ;
Lim, L ;
Tao, Z ;
Peng, CK ;
Ean, LOL ;
Lee, NM ;
Sin, LY ;
Ng, LFP ;
Chee, RE ;
Stanton, LW ;
Long, PM ;
Liu, ET .
LANCET, 2003, 361 (9371) :1779-1785
[52]   Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) [J].
Seto, WH ;
Tsang, D ;
Yung, RWH ;
Ching, TY ;
Ng, TK ;
Ho, M ;
Ho, LM ;
Peiris, JSM .
LANCET, 2003, 361 (9368) :1519-1520
[53]   Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections [J].
Sizun, J ;
Yu, MWN ;
Talbot, PJ .
JOURNAL OF HOSPITAL INFECTION, 2000, 46 (01) :55-60
[54]   Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage [J].
Snijder, EJ ;
Bredenbeek, PJ ;
Dobbe, JC ;
Thiel, V ;
Ziebuhr, J ;
Poon, LLM ;
Guan, Y ;
Rozanov, M ;
Spaan, WJM ;
Gorbalenya, AE .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 331 (05) :991-1004
[55]   Development of a standard treatment protocol for severe acute respiratory syndrome [J].
So, LKY ;
Lau, ACW ;
Yam, LYC ;
Cheung, TMT ;
Poon, E ;
Yung, RWH ;
Yuen, KY .
LANCET, 2003, 361 (9369) :1615-1617
[56]   A multicentre collaboration to investigate the cause of severe acute respiratory syndrome [J].
Stöhr, K .
LANCET, 2003, 361 (9370) :1730-1733
[57]   Mechanisms and enzymes involved in SARS coronavirus genome expression [J].
Thiel, V ;
Ivanov, KA ;
Putics, A ;
Hertzig, T ;
Schelle, B ;
Bayer, S ;
Weissbrich, B ;
Snijder, EJ ;
Rabenau, H ;
Doerr, HW ;
Gorbalenya, AE ;
Ziebuhr, J .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2305-2315
[58]  
TSANG KW, 2000, NEW ENGL J MED, V348, P1977
[59]   Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome [J].
Tsui, SKW ;
Chim, SSC ;
Lo, YMD .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :187-188
[60]  
*WHO, 2003, WKLY EPIDEMIOL REC, V78, P258